SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19

Abstract

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess whether SARS‐CoV‐2‐neutralising mAbs are effective and safe for treating patients with COVID‐19 in comparison to an active comparator, placebo or no intervention, and to maintain the currency of the evidence, using a living systematic review approach. A secondary objective is to track newly developing SARS‐CoV‐2‐targeting mAbs from first tests in humans onwards.